SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vestor who wrote (224)11/29/1999 8:24:00 AM
From: Bob Davis   of 315
 
On June 22, 1998, when CLZR was $3.00 per share and earnings per share were showing a loss, The Napeague Letter sent its readers a "quick heads up to alert you to what may be a developing situation with Candela." Subsequently, on May 12, 1999 CLZR hit $22.00 a share, a 633% increase in 11 months.

Although the stock subsequently dropped back, it is now showing technical strength and regaining lost ground. At the end of October, CLZR announced very strong first quarter results, and market awareness in the stock has clearly grown during November. Although no analysts followed the stock at the end of June last year, it now has five analysts, all of whom have "buy" recommendations on the stock.

The Napeague Letter gives its readers in-depth, on-going, fundamental Analysis of carefully-selected undervalued small-cap stocks. A recent article on the Money magazine web site listed The Napeague Letter among "the best small-company stock sites the web has to offer." The URL for the Napeague site can be found by clicking on the "Bob Davis", in blue, at the top of this posting.

Bob Davis
The Napeague Letter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext